NEUPOGEN

Google image searchProduct monograph

Active ingredient

filgrastim, 300 MCG/ML

DIN: 01968017

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: VIALS

Schedule: Prescription / Schedule D

Company: AMGEN CANADA INC

Date: 20-JUN-2002

ATC:

Reference brand drug: Neupogen

Pharmaceutical standard: MFR

Search on Google